Luigi Mangione’s legal team argues that Attorney General Pam Bondi’s decision to pursue the death penalty against him for the murder of UnitedHealthcare CEO Brian Thompson in New York City is compromised by her previous employment at a lobbying firm representing the insurer’s parent company. Bondi’s role at Ballard Partners before taking charge at the Justice Department, where she pushed for Mangione’s federal case to escalate to a capital offense, is seen as a significant conflict of interest that violates his due process rights. They are requesting the exclusion of the death penalty and certain charges, with a hearing set for January 9.
The defense claims that Bondi’s involvement in the death penalty determination, coupled with public statements implying Mangione’s eligibility for execution, contradicts her pledge to comply with ethical guidelines and abstain from matters related to Ballard clients for a year upon assuming office. They insist that Bondi’s continued financial ties to Ballard, as well as its association with UnitedHealth Group, through profit-sharing agreements and administrative roles, create a situation where the individual responsible for pursuing Mangione’s death has a vested financial interest in the case. They argue that this conflict of interest should have prompted Bondi to recuse herself from any involvement in the case.
Efforts to obtain comments from the Justice Department and Ballard Partners were unsuccessful. Bondi’s directive in April for federal prosecutors to pursue the death penalty for Mangione, even prior to his formal indictment, was based on the belief that the killing was a premeditated and cold-blooded act. Thompson was fatally shot on December 4, 2024, while en route to a Manhattan hotel for UnitedHealth Group’s annual investor conference. Mangione, aged 27, was apprehended five days post the incident and has pleaded not guilty to both federal and state charges, with state charges carrying a potential life imprisonment sentence. Trial schedules for both cases remain pending.
Following a lengthy pretrial session focused on suppressing key evidence from his arrest, Mangione’s defense team is emphasizing Bondi’s lobbying background in their plea to U.S. District Judge Margaret Garnett to eliminate the death penalty option, dismiss some charges, and exclude contested evidence from the state proceedings. They assert that Bondi’s decision to advocate for the death penalty, accompanied by public engagements such as Instagram posts and TV appearances, indicates a politically motivated stance rather than a merit-based judgment. They also argue that Bondi’s actions have prejudiced the case and infringed upon Mangione’s constitutional rights.
Federal prosecutors countered the defense’s claims by stating that intense pretrial publicity does not constitute a constitutional flaw. They propose that prospective jurors be thoroughly vetted for their awareness of the case and guarantee Mangione’s fair treatment during the trial to address the defense’s concerns. The prosecutors dismiss the defense’s portrayal of a constitutional crisis, asserting that these arguments have been previously rejected in similar cases and do not warrant the dismissal of charges or a blanket prohibition on a legally permissible punishment.
Mangione’s legal representatives are intent on investigating Bondi’s connections to Ballard and its dealings with UnitedHealth Group. They intend to request various documents, including details of Bondi’s compensation from the firm, any directives given to Justice Department personnel regarding the case or UnitedHealthcare, and sworn testimonies from individuals with pertinent knowledge.
